Selank

Selank 10 mg is a synthetic heptapeptide offered by SARMs Revolution Lab for laboratory research in Canada. Its reported sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, derived from the immunomodulatory peptide tuftsin.

Selank 10 mg research product information

Sequence, concentration and batch documentation should be evaluated independently. This product should not be assumed equivalent to any medicine studied or marketed outside Canada.

What is Selank?

Selank is discussed in literature on GABA-receptor modulation, enkephalin metabolism, stress models and behavioural pharmacology. A 2018 review describes molecular experiments involving GABA binding, while animal studies investigate stress-related behaviours.

A small body of clinical literature, much of it published in Russian-language journals and limited populations, has examined anxiety-related outcomes. Those studies do not establish broad efficacy, Canadian authorization or equivalence for this 10 mg research vial.

How should Selank evidence be interpreted?

Cell-membrane binding studies, rodent behaviour models and small comparative human studies answer different questions. Results should be interpreted according to design, sample size, comparator, route, formulation and publication context.

This page therefore does not promise reduced anxiety, improved focus, better sleep, mood enhancement or cognitive performance. It provides the evidence map without converting research observations into consumer outcomes.

Selank status and research limits in Canada

Researchers should verify product identity and regulatory status independently. This page does not provide diagnosis, psychiatric treatment, dosage, nasal use, reconstitution or administration instructions.

Selank 10 mg frequently asked questions

What is the Selank sequence?

Published literature describes the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro.

How much Selank is supplied?

The SRL listing identifies one 10 mg vial. Confirm the label and batch documentation.

Is Selank evidence mostly Canadian clinical research?

No. Much of the cited work comes from Russian research groups, and several key experiments are preclinical.

Does Selank research prove an anxiety treatment?

No conclusion about this vial or Canadian therapeutic use should be drawn from the limited literature.

Does this page provide a protocol?

No. It does not provide dosing, nasal-use, reconstitution or self-administration instructions.

Where can related research products be viewed?

See the Semax research page and the SRL peptide category.

Scientific references

• Review of molecular aspects of Selank activity. 2018.
• Small comparative clinical study of Selank in anxiety disorders. 2008.
• Selank and diazepam in a chronic-stress rat model. 2017.

Research-use notice: Selank 10 mg is offered strictly for laboratory research and analytical work. It is not intended for human consumption, self-administration, diagnosis, treatment or veterinary use.